Evidence map›Paper›PMID 26457720›Full record

ReviewVaccines2015

Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform.

Pavimol Angsantikul, Soracha Thamphiwatana, Weiwei Gao, Liangfang Zhang

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Vaccines, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Erythrocyte-Inspired Functional Materials for Biomedical Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  10. Review
  11. Review
  12. Review
  13. Bacteria-Inspired Nanomedicine.ACS applied bio materials · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Pavimol AngsantikulDepartment of NanoEngineering and Moores Cancer Center, University of California, La Jolla, San Diego, CA 92093, USA. pangsant@ucsd.edu.
Soracha ThamphiwatanaDepartment of NanoEngineering and Moores Cancer Center, University of California, La Jolla, San Diego, CA 92093, USA. sthamphi@ucsd.edu.
Weiwei GaoDepartment of NanoEngineering and Moores Cancer Center, University of California, La Jolla, San Diego, CA 92093, USA. w5gao@ucsd.edu.
Liangfang ZhangDepartment of NanoEngineering and Moores Cancer Center, University of California, La Jolla, San Diego, CA 92093, USA. zhang@ucsd.edu.
University of California, San Diego · USMoores Cancer Center

Funding

Innate Antimicrobial Nanotherapeutics for the Treatment of H. pylori InfectionR01DK095168 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZHANG, LIANGFANG · 2012 to 2016
$1.6M
NIDDK NIH HHS R01 DK095168
6 · The paper itself

Abstract

Nanoparticles have demonstrated unique advantages in enhancing immunotherapy potency and have drawn increasing interest in developing safe and effective vaccine formulations. Recent technological advancement has led to the discovery and development of cell membrane-coated nanoparticles, which combine the rich functionalities of cellular membranes and the engineering flexibility of synthetic nanomaterials. This new class of biomimetic nanoparticles has inspired novel vaccine design strategies with strong potential for modulating antibacterial immunity. This article will review recent progress on using cell membrane-coated nanoparticles for antibacterial vaccination. Specifically, two major development strategies will be discussed, namely (i) vaccination against virulence factors through bacterial toxin sequestration; and (ii) vaccination against pathogens through mimicking bacterial antigen presentation.

Indexed as

biomimetic nanoparticleinfectious diseasemembrane coatingnanomedicinenanovaccine

Identifiers

PMID26457720
PMCPMC4693220
OpenAlexW1840154351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.